Molbank (Jan 2021)

<i>N</i>-(6-Chloro-3-nitropyridin-2-yl)-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)isoquinolin-3-amine

  • Valentin Wydra,
  • Stefan Gerstenecker,
  • Dieter Schollmeyer,
  • Stanislav Andreev,
  • Teodor Dimitrov,
  • Ricardo Augusto Massarico Serafim,
  • Stefan Laufer,
  • Matthias Gehringer

DOI
https://doi.org/10.3390/M1181
Journal volume & issue
Vol. 2021, no. 1
p. M1181

Abstract

Read online

Here we describe the synthesis of N-(6-chloro-3-nitropyridin-2-yl)5-(1-methyl-1H-pyrazol-4-yl)isoquinolin-3-amine via a three-step procedure including a Buchwald–Hartwig arylamination with benzophenone imine and a highly regioselective nucleophilic aromatic substitution. The title compound was analyzed by nuclear magnetic resonance spectroscopy (1H, 13C, HSQC, HMBC, COSY, DEPT90 and NOESY), high resolution mass spectrometry (ESI-TOF-HRMS) and infrared spectroscopy (ATR-IR) and its structure was confirmed by single crystal X-ray diffraction. The inhibitory potency of the title compound was evaluated for selected kinases harboring a rare cysteine in the hinge region (MPS1, MAPKAPK2 and p70S6Kβ/S6K2).

Keywords